ABSTRACT
INTRODUCTION/OBJECTIVES: Balloon instability is commonly encountered during balloon pulmonary valvuloplasty (BPV) and may result in an unsuccessful procedure. The NuCLEUS-X™ catheter is a recently developed BPV catheter with a unique barbell shape and an ordered pattern of inflation that stabilizes the balloon to span the valve annulus before expansion of the balloon center. ANIMALS: Ten client-owned dogs with severe valvular pulmonic stenosis (PS). MATERIALS AND METHODS: Prospective observational study. The BPV procedure was performed by standard technique with use of NuCLEUS-X™ catheters targeting a balloon-to-annulus ratio between 1.2 and 1.5. Balloon stability, safety, and procedural success were assessed. Procedural success was defined as either a reduction in the Doppler transpulmonic PG by at least 50% of the pre-procedural PG or <80 mmHg one month post procedure. RESULTS: Balloon stability centered at the pulmonic valve on the first inflation was achieved in 10/10 cases. The mean PG before BPV was 141 mmHg ±41 mmHg, and the PG after BPV at one month was 83 mmHg ±41 mmHg. Procedural success was achieved in 56% of patients. All dogs survived the BPV, and no major procedural complications were encountered using the NuCLEUS-X™ catheter. CONCLUSIONS: The use of the NuCLEUS-X™ catheter is feasible for BPV in dogs with severe PS. The unique balloon shape provided catheter stability on the first inflation in all dogs, which may be beneficial when stabilization of a conventional BPV catheter cannot be achieved.
Subject(s)
Balloon Valvuloplasty/veterinary , Dog Diseases/therapy , Pulmonary Valve Stenosis/veterinary , Animals , Balloon Valvuloplasty/instrumentation , Blood Pressure , Cardiac Catheters , Dog Diseases/congenital , Dogs , Prospective Studies , Pulmonary Valve Stenosis/congenital , Pulmonary Valve Stenosis/therapy , Treatment OutcomeABSTRACT
INTRODUCTION: Overall complication rates associated with a wide range of diagnostic and therapeutic interventional cardiac procedures in a contemporary academic setting have not been reported. ANIMALS, MATERIALS AND METHODS: Consecutive interventional procedures performed for client-owned dogs were retrospectively analyzed to characterize procedural complications and mortality. RESULTS: Three hundred sixty-four procedures were performed on 336 dogs. Interventions included attempted or completed transvenous pacemaker (PM) implantation (n = 134) with subsequent pacing system revision (n = 8), pulmonic balloon valvuloplasty (BVP) (n = 117) with a subset of patients undergoing an additional BVP (n = 14), transarterial closure of left-to-right shunting patent ductus arteriosus (PDA) (n = 66), diagnostic angiography and/or cardiovascular pressure measurement (n = 9), transvenous temporary pacing (n = 7), septal defect occlusion (n = 5), heartworm extraction (n = 3), and BVP catheter fragment retrieval (n = 1). The prevalence of major perioperative and postoperative complications for all procedures was 5% and 6%, respectively, and the procedural mortality rate was 2%. The overall rate of major complications was 12% for the PM group, 11% for the BVP group, and 2% for the PDA occlusion group. Both PM implantation and BVP have higher rates of major complications overall compared with PDA occlusion (p=0.0151). CONCLUSIONS: The results of this study indicate that the prevalence of major complications and mortality associated with interventional cardiac procedures is low; however, significant differences exist in complication rates between procedures.
Subject(s)
Cardiovascular Surgical Procedures/veterinary , Dog Diseases/surgery , Postoperative Complications/veterinary , Animals , Cardiovascular Surgical Procedures/mortality , Cardiovascular Surgical Procedures/statistics & numerical data , Dog Diseases/mortality , Dogs , Female , Male , Oregon , Postoperative Complications/epidemiology , Postoperative Complications/mortality , Prevalence , Retrospective StudiesABSTRACT
A 2-year old intact male Collie dog presented to the cardiology service at Oregon State University for evaluation of cyanosis and suspected congenital cardiac disease. Echocardiography revealed a constellation of cardiac abnormalities including a single large vessel exiting the right ventricle with a diminutive left ventricular outflow tract, a ventricular septal defect, and marked concentric right ventricular hypertrophy with moderate right atrial dilation. Cardiac-gated computed tomography confirmed the previous anomalies in addition to supporting a diagnosis of complete transposition of the great arteries, double outlet right ventricle, and pulmonic hypoplasia with a single coronary ostium. Prominent bronchoesophageal collateral vessels were concurrently identified. Clinically, the dog was stable despite mild cyanosis that worsened with exercise; no intervention was elected at the time. This case report describes a rare combination of congenital cardiac defects and the usefulness of cardiac-gated cross-sectional imaging in the anatomic diagnosis.
Subject(s)
Dogs/abnormalities , Double Outlet Right Ventricle/veterinary , Animals , Aorta/abnormalities , Double Outlet Right Ventricle/diagnostic imaging , Echocardiography/veterinary , Male , Pulmonary Artery/abnormalitiesSubject(s)
Cat Diseases/diagnostic imaging , Dog Diseases/diagnosis , Heart Murmurs/veterinary , Animals , Cat Diseases/classification , Cat Diseases/etiology , Cats , Dog Diseases/diagnostic imaging , Dog Diseases/therapy , Dogs , Echocardiography/veterinary , Heart Murmurs/diagnosis , Heart Murmurs/diagnostic imaging , Heart Murmurs/therapy , Incidental Findings , Mitral Valve Insufficiency/diagnostic imaging , Mitral Valve Insufficiency/veterinaryABSTRACT
BACKGROUND: Myocardial disease in the Boxer dog is characterized by 1 of 2 clinical presentations, dilated cardiomyopathy (DCM) characterized by ventricular systolic dysfunction, dilatation and tachyarrhythmias, and arrhythmogenic right ventricular cardiomyopathy (ARVC) characterized by ventricular tachyarrhythmias, syncope, and sudden death. Boxer ARVC has been associated with a deletion in the striatin gene in some families. HYPOTHESIS/OBJECTIVES: We hypothesized that both presentations represent a single disease, and the development of DCM in the Boxer is associated with the striatin deletion. ANIMALS: Thirty-three adult Boxer dogs with DCM, 29 adult Boxer dogs with the striatin deletion and ARVC, and 16 Boxers without cardiac disease. METHODS: DNA samples were evaluated for the striatin deletion. Association of the deletion with the DCM phenotype was tested by a Fisher's exact test. T-tests were used to evaluate potential differences between the positive heterozygous and positive homozygous groups with DCM with regard to age, LVIDD, LVIDS, and FS%. RESULTS: Thirty of 33 dogs with DCM were positive for the striatin deletion. The striatin mutation and the homozygous genotype were strongly associated with the DCM phenotype (P < .001 and P = .005). There was no statistical difference between the heterozygous and homozygous groups with regard to age and echocardiographic measurements. CONCLUSIONS AND CLINICAL IMPORTANCE: This study demonstrates an association between DCM in the Boxer dog and the striatin mutation, particularly with the homozygous genotype. The observation that 3/33 dogs developed DCM and lacked the striatin mutation suggests that there is at least 1 other cause of DCM in the Boxer dog.
Subject(s)
Arrhythmogenic Right Ventricular Dysplasia/veterinary , Cardiomyopathy, Dilated/veterinary , Dog Diseases/physiopathology , Membrane Proteins/genetics , Animals , Arrhythmogenic Right Ventricular Dysplasia/genetics , Arrhythmogenic Right Ventricular Dysplasia/physiopathology , Cardiomyopathy, Dilated/genetics , Cardiomyopathy, Dilated/physiopathology , Case-Control Studies , Confidence Intervals , DNA/chemistry , DNA/genetics , Dog Diseases/genetics , Dogs , Echocardiography/veterinary , Female , Genotype , Male , Polymerase Chain Reaction/veterinary , Sequence Deletion/geneticsABSTRACT
BACKGROUND: A description of the clinical signs and necropsy findings in 10 alpacas with thrombotic endocarditis. ANIMALS: Clinical cases admitted to 2 veterinary referral hospitals between May 1998 and December 2006. METHODS: A retrospective study was performed by searching hospital records to identify alpacas diagnosed with endocarditis. RESULTS: Common clinical findings included sternal recumbency, tachycardia, tachypnea, and abdominal distension. Heart sounds were recorded as normal in 7 of 10 alpacas. Pleural and pericardial effusion and ascites were often present. Complete blood cell counts often suggested inflammation, and liver enzyme activity was often increased. When echocardiography was performed, a soft tissue density was imaged within the right ventricle. All alpacas died or were euthanized. Necropsy revealed mural endocarditis with right ventricular or biventricular fibrinous thrombi obliterating the ventricular lumina with no valvular involvement in 6 of 10 affected animals. Bacteria were not consistently identified as a cause for the endocarditic lesions. Eight of the 10 alpacas had evidence of hepatic fluke infestation. CONCLUSIONS AND CLINICAL IMPORTANCE: Valvular and mural thrombotic endocarditis should be included in the list of differential diagnoses for hepatomegaly, abdominal distension, and other signs of right-sided congestive heart failure in alpacas. The prognosis of this disease is grave.
Subject(s)
Camelids, New World , Endocarditis/veterinary , Thrombosis/veterinary , Animals , Blood Chemical Analysis/veterinary , Endocarditis/blood , Endocarditis/pathology , Female , Male , Retrospective Studies , Thrombosis/blood , Thrombosis/pathologyABSTRACT
Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are cardiac hormones involved in electrolyte and fluid homeostasis. Our laboratory has investigated the use of ANP and BNP as diagnostic markers of cardiac disease in cats. We hypothesize that the cardiac distribution of ANP and BNP increases in cats with hypertrophic cardiomyopathy (HCM). Accordingly, we evaluated the immunohistochemical distribution of ANP and BNP in hearts of four cats with naturally occurring HCM relative to five healthy controls. Indirect immunoperoxidase was performed with polyclonal immunoglobulin G against feline ANP (1-28) and proBNP (43-56). In control cats, ANP and BNP immunoreactivity was restricted to the atria. Staining for both peptides was most intense adjacent to the endocardial surface. Auricles stained more diffusely than atria for both peptides. The interstitial capillaries and nerve fibers within the heart were positive only for BNP. Atrial immunoreactivity for ANP and BNP was more diffuse and had a less distinctly layered pattern in HCM than in control cats. Ventricular cardiomyocytes of HCM cats were negative for ANP but stained lightly and diffusely for BNP. The capillaries and nerve fibers remained positive for BNP. We conclude that in cats with HCM, the cardiac distribution of ANP and BNP is more diffuse in the atria and that novel expression of BNP in the ventricular cardiomyocytes occurs.
Subject(s)
Atrial Natriuretic Factor/metabolism , Cardiomyopathy, Hypertrophic/veterinary , Cat Diseases/metabolism , Natriuretic Peptide, Brain/metabolism , Animals , Cardiomyopathy, Hypertrophic/metabolism , Cardiomyopathy, Hypertrophic/pathology , Cat Diseases/pathology , Cats , Heart Atria/metabolism , Heart Atria/pathology , Heart Ventricles/metabolism , Heart Ventricles/pathology , Immunohistochemistry/veterinaryABSTRACT
An 8-month-old, male domestic shorthaired cat presented for chronic weight loss, intermittent dyspnea, chronic diarrhea, hyperactivity, and weakness. The cat had a palpable thyroid nodule and increased serum total thyroxine and 3,5,3' triiodothyronine levels. The cat was diagnosed with hyperthyroidism, and a unilateral thyroidectomy was performed followed by radioactive iodine at a later date. The clinical signs resolved following radioactive iodine, and the cat subsequently developed clinical hypothyroidism.
Subject(s)
Cat Diseases/diagnosis , Hyperthyroidism/veterinary , Animals , Cat Diseases/blood , Cat Diseases/pathology , Cat Diseases/surgery , Cats , Diagnosis, Differential , Diarrhea/etiology , Diarrhea/veterinary , Dyspnea/etiology , Dyspnea/veterinary , Hyperthyroidism/blood , Hyperthyroidism/complications , Hyperthyroidism/diagnosis , Male , Thyroidectomy/veterinary , Thyroxine/blood , Triiodothyronine/blood , Weight LossABSTRACT
OBJECTIVE: To evaluate the cardiovascular effects of the alpha2-adrenergic receptor agonist medetomidine hydrochloride in clinically normal cats. ANIMALS: 7 clinically normal cats. PROCEDURE: Cats were anesthetized with isoflurane, and thermodilution catheters were placed for measurement of central venous, pulmonary, and pulmonary capillary wedge pressures and for determination of cardiac output. The dorsal pedal artery was catheterized for measurement of arterial blood pressures and blood gas tensions. Baseline variables were recorded, and medetomidine (20 microg/kg of body weight, IM) was administered. Hemodynamic measurements were repeated 15 and 30 minutes after medetomidine administration. RESULTS: Heart rate, cardiac index, stroke index, rate-pressure product, and right and left ventricular stroke work index significantly decreased from baseline after medetomidine administration, whereas systemic vascular resistance and central venous pressure increased. However, systolic, mean, and diastolic arterial pressures as well as arterial pH, and oxygen and carbon dioxide tensions were not significantly different from baseline values. CONCLUSIONS AND CLINICAL RELEVANCE: When administered alone to clinically normal cats, medetomidine (20 microg/kg, IM) induced a significant decrease in cardiac output, stroke volume, and heart rate. Arterial blood pressures did not increase, which may reflect a predominant central alpha2-adrenergic effect over peripheral vascular effects.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Cats/physiology , Hemodynamics/drug effects , Medetomidine/pharmacology , Anesthetics, Inhalation/administration & dosage , Animals , Blood Gas Analysis/veterinary , Blood Pressure/drug effects , Cardiac Output/drug effects , Female , Heart Rate/drug effects , Isoflurane/administration & dosage , MaleABSTRACT
Evaluation of canine congenital heart disease presents a diagnostic challenge to many ultrasonographers. To assist clinicians attempting to examine these patients, an echocardiographic algorithm containing the six most common canine congenital heart diseases (i.e., patent ductus arteriosus, subaortic stenosis, pulmonic stenosis, ventricular septal defect, tricuspid dysplasia, and tetralogy of Fallot) is presented. The algorithm focuses on the underlying disease pathogenesis and the resultant changes in cardiac structure and function that can be readily identified during echocardiographic examination. Use of this algorithm provides a framework from which the ultrasonographer gains both experience and confidence in diagnosing congenital heart disease via echocardiography. This algorithm is supported by a number of still figures within the article as well as real-time echocardiographic images available for viewing at AAHA's website, www.aahanet.org.
Subject(s)
Dog Diseases/diagnostic imaging , Heart Defects, Congenital/veterinary , Algorithms , Animals , Aortic Stenosis, Subvalvular/diagnostic imaging , Aortic Stenosis, Subvalvular/veterinary , Decision Trees , Diagnosis, Differential , Dogs , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/veterinary , Echocardiography/veterinary , Heart Defects, Congenital/diagnostic imaging , Heart Septal Defects/diagnostic imaging , Heart Septal Defects/veterinary , Pulmonary Valve Stenosis/diagnostic imaging , Pulmonary Valve Stenosis/veterinary , Tetralogy of Fallot/diagnostic imaging , Tetralogy of Fallot/veterinary , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve Insufficiency/veterinaryABSTRACT
Artificial pacing (AP) is a treatment for symptomatic bradyarrhythmias unresponsive to medical therapy. This retrospective study was designed to define the practices and outcome of AP in dogs at 7 referral institutions participating in the Companion Animal Pacemaker Registry and Repository (CANPACERS). The indications, implantation techniques, complications, long-term outcome, and owner satisfaction were examined. One hundred fifty-four dogs were identified as undergoing AP from January 1, 1991, to January 1, 1996. Third-degree atrioventricular (AV) block (n = 91; 59%) and sinus node dysfunction (n = 45; 29%) were the most common indications for AP Transvenous endocardial AP systems were implanted in 136 dogs (88%), and epicardial systems were implanted in 18 (12%). Complications associated with AP were reported in 84 dogs (55%). Major complications occurred in 51 dogs (33%), including dislodgement of the pacing lead (n = 15; 10%), generator failure (n = 10; 6%), cardiac arrest during implantation (n = 9; 6%), and infection (n = 7; 5%). Minor complications occurred in 47 dogs (31%), including seroma formation (n = 18; 12%), muscle twitch (n = 17; 11%), and inconsequential arrhythmias (n = 15; 10%). Fourteen dogs (9%) experienced both major and minor complications. Survival analysis revealed 1-, 2-, and 3-year survival rates of 70, 57, and 45%, respectively. Age and presence of preexisting congestive heart failure (CHF) had a negative effect on survival (P = .001). Sixty percent of dogs with preexisting CHF died within 1 year of implantation, whereas 25% of dogs without heart failure died during the same period. Owners rated their satisfaction with the procedure as high in 80% of the dogs.
Subject(s)
Arrhythmias, Cardiac/veterinary , Cardiac Pacing, Artificial/veterinary , Dog Diseases/therapy , Animals , Arrhythmias, Cardiac/therapy , Cardiac Pacing, Artificial/adverse effects , Dog Diseases/mortality , Dogs , Equipment Failure , Female , Male , Proportional Hazards Models , Records/veterinary , Retrospective Studies , Risk Factors , Survival Analysis , Treatment Outcome , United States , Veterinary Medicine/statistics & numerical dataABSTRACT
A six-year-old cat presented with clinical signs consistent with distal aortic thromboembolism while clinical signs of cardiovascular disease were absent. Diagnostics, including thoracic radiographs, electrocardiography, and echocardiography revealed no cardiovascular anomalies. Thoracic radiographs revealed multifocal pulmonary lesions consistent with neoplasia. Complete blood cell count demonstrated a marked thrombocytosis, leukopenia, and neutropenia. Histopathology of the pulmonary lesions confirmed multiple bronchoalveolar carcinomas. Myelodysplasia with megakaryocytic hyperplasia and ineffective myelopoiesis was noted on bone-marrow histopathology from multiple sites. The absence of other causes suggested a paraneoplastic thrombocytosis. The diagnosis of paraneoplastic thrombocytosis-induced thromboembolism was made due to the lack of underlying cardiac disease and the presence of a marked thrombocytosis. The presence of thrombocytosis and thromboembolism associated with neoplasia is discussed.
Subject(s)
Cat Diseases/diagnosis , Lung Neoplasms/veterinary , Paraneoplastic Syndromes/veterinary , Thrombocytosis/veterinary , Thromboembolism/veterinary , Animals , Aorta, Thoracic/diagnostic imaging , Bone Marrow/pathology , Cat Diseases/diagnostic imaging , Cat Diseases/etiology , Cats , Diagnosis, Differential , Euthanasia/veterinary , Fatal Outcome , Lung/pathology , Lung Neoplasms/complications , Lung Neoplasms/diagnosis , Male , Paraneoplastic Syndromes/complications , Paraneoplastic Syndromes/diagnosis , Radiography , Thrombocytosis/complications , Thrombocytosis/diagnosis , Thromboembolism/diagnostic imaging , Thromboembolism/etiologySubject(s)
Atrial Fibrillation/veterinary , Dog Diseases/diagnosis , Electrocardiography/veterinary , Heart Block/veterinary , Animals , Atrial Fibrillation/complications , Atrial Fibrillation/diagnosis , Dog Diseases/physiopathology , Dogs , Heart Block/complications , Heart Block/diagnosis , Male , Quadriplegia/complications , Quadriplegia/etiology , Quadriplegia/veterinary , Spinal Cord Compression/complications , Spinal Cord Compression/surgery , Spinal Cord Compression/veterinaryABSTRACT
Blood pressure (BP) measurements obtained using 3 indirect BP measuring instruments, a Doppler ultrasonic flowmeter, an oscillometric device, and a photoplethysmograph, were compared with direct arterial pressure measurements in 11 anesthetized cats. The standard deviation of the differences (SDD) between direct and indirect pressure measurements were not significantly different from each other (P < .01), and ranged from 10.82 to 24.32 mm Hg. The high SDD values indicate that indirect BP estimates obtained with all these devices must be interpreted cautiously in individual patients. The mean errors (calculated as the sum of the differences between direct and indirect pressure measurements divided by the number of observations) of the 3 indirect devices were significantly different for systolic (SAP), diastolic (DAP), and mean (MAP) arterial pressures (P < .05). The Doppler and photoplethysmographic devices had the highest overall accuracy, as indicated by mean error values of less than 10 mm Hg. Correlation coefficients varied from .88 to .96 for the Doppler flowmeter, and from .85 to .94 for the photoplethysmograph; for both devices, the regression line slopes were close to unity. The Doppler flowmeter detected a pulse under all experimental conditions. The photoplethysmograph was also efficient in obtaining BP measurements, obtaining over 90% of SAP, DAP, and MAP readings attempted. The oscillometric device was the least accurate, with mean error values varying from 10 to 22 mm Hg. Correlation coefficients were high (.90 to .94) for this device, but the slopes of the regression lines were 0.7 to 0.8, indicating a trend for increased error at higher BP. The oscillometric device tended to underestimate BP by increasing amounts as the BP increased. The oscillometric device was the least efficient device for obtaining BP measurements (P < .01).
Subject(s)
Anesthesia/veterinary , Blood Pressure/physiology , Cats/physiology , Analysis of Variance , Animals , Bias , Oscillometry/veterinary , Photoplethysmography/veterinary , Regression Analysis , Ultrasonography, Doppler/veterinaryABSTRACT
The systemic toxicity of doxorubicin, 30 mg/m2 body surface area (BSA) every 21 days to a cumulative dose of 300 mg/m2, was evaluated in six cats. Appetite, body weight, and the presence of vomiting and/or diarrhea were monitored throughout the study. Renal function was monitored by measuring serum blood urea nitrogen (BUN) and creatinine concentrations, urine specific gravity, and creatinine clearance before each treatment. Electrocardiograms and echocardiograms were also done before each treatment. The cats were killed 3 weeks after the last treatment, and complete necropsies were performed. Partial or complete anorexia occurred in all cats with significant weight loss occurring after a cumulative doxorubicin dose of 150 mg/m2 BSA. Mild vomiting and diarrhea that required no treatment also occurred sporadically in all cats. Echocardiographic changes consistent with doxorubicin-induced cardiomyopathy occurred in four cats after cumulative doses of 170 to 240 mg/m2 BSA. Clinical heart disease and electrocardiographic changes were not observed. Subsequent histological examination revealed myocyte vacuolization and myocytolysis in all six hearts. Renal dysfunction, characterized by increasing azotemia with progressively more dilute urine, was detected in two cats. Mean creatinine clearance values also decreased significantly throughout the study. At necropsy, all cats had histological evidence of renal disease.
Subject(s)
Cat Diseases/chemically induced , Doxorubicin/toxicity , Animals , Anorexia/chemically induced , Anorexia/pathology , Anorexia/veterinary , Cat Diseases/pathology , Cats , Digestive System/drug effects , Digestive System/pathology , Doxorubicin/administration & dosage , Female , Heart/drug effects , Kidney/drug effects , Kidney/pathology , MaleABSTRACT
Epidemiologic relations were evaluated between plasma concentrations of nutrients and cardiovascular diseases. A total of 220 cats were assessed: 144 cats with noninduced acquired heart disease and 76 clinically normal cats. Plasma was assayed for taurine, alpha-tocopherol, selenium, retinol, and total cholesterol and triglycerides concentrations. Cardiovascular disease groups included dilated cardiomyopathy (n = 53), left ventricular hypertrophy (n = 28), hyperthyroidism (n = 11), and uncertain classification (n = 52). In cats with dilated cardiomyopathy, mean plasma taurine concentration was the lowest of that in cats of any group, being only 38% of the value in healthy cats; females had less than half the mean value of males. Tocopherol concentration was 20% lower than normal, and retinol concentration was 40% higher than normal. Total cholesterol concentration was 36% lower than normal. Triglycerides concentration was higher in these cats than in any other group--twice the value recorded in healthy cats and 67% higher than that in hyperthyroid cats. In cats with hypertrophic cardiomyopathy, almost 15% had mean plasma taurine concentration < 30 mumol/L. Retinol concentration was 15% higher, and triglycerides concentration was 54% higher than normal. Approximately 27% of hyperthyroid cats had mildly decreased plasma taurine concentration. Hyperthyroid cats had the lowest tocopherol and cholesterol values; both were at least 30% lower than normal. Retinol concentration was 30% higher than normal. Approximately 14% of cats with uncertain classification had mildly decreased plasma taurine concentration. Plasma retinol and triglycerides concentrations were higher than normal in 25 and 38% of these cats, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Cardiovascular Diseases/veterinary , Cat Diseases/blood , Cats/blood , Animals , Cardiomyopathy, Dilated/blood , Cardiomyopathy, Dilated/veterinary , Cardiovascular Diseases/blood , Cholesterol/blood , Female , Hyperthyroidism/blood , Hyperthyroidism/veterinary , Hypertrophy, Left Ventricular/blood , Hypertrophy, Left Ventricular/veterinary , Male , Reference Values , Selenium/blood , Sex Factors , Taurine/blood , Triglycerides/blood , Vitamin A/blood , Vitamin E/bloodABSTRACT
M-mode echocardiography was completed and plasma taurine concentrations were determined in 79 healthy cats and 77 cats with dilated cardiomyopathy (DCM). In healthy cats, a relationship was not observed between plasma taurine concentrations and any M-mode echocardiographic measurement. End-systolic and end-diastolic cardiac chamber dimensions were larger; wall thickness measures were smaller; and calculations of fractional shortening were less in cats with DCM than in healthy cats. Plasma taurine concentrations less than 30 nmol/mL were detected in 7/79 healthy cats and in 52/77 cats with DCM. Of the 52 cats with DCM and an initial plasma taurine concentration less than 30 nmol/mL, 23 died or were euthanized during the first post-treatment week, 7 were lost to further study, and 22 improved after taurine supplementation. Of the 25 cats with DCM and an initial plasma taurine concentration greater than or equal to 30 nmol/mL, 9 died or were euthanatized during the first post-treatment week, and 9 were lost to further study. Two cats did not improve, of which one died and one was euthanatized 4 to 8 weeks after initiation of taurine supplementation. Five cats with a plasma taurine concentration greater than or equal to 30 nmol/mL improved after taurine supplementation. Myocardial function subsequently deteriorated in three of these cats. Two of the three cats had signs of congestive heart failure redevelop.
Subject(s)
Cardiomyopathy, Dilated/veterinary , Cat Diseases/blood , Echocardiography/veterinary , Taurine/blood , Animals , Body Weight , Cardiomyopathy, Dilated/blood , Cardiomyopathy, Dilated/diagnostic imaging , Cat Diseases/diagnostic imaging , Cats , Female , Male , Regression AnalysisABSTRACT
Left ventricular ejection fractions (LVEF) of 8 pentobarbital-anesthetized dogs were calculated by gated equilibrium radionuclide ventriculography (RVG) and by M-mode and two-dimensional echocardiography (2-DE) prior to and during constant IV infusion of isoproterenol. Mean LVEF (+/- SD), determined with RVG by use of an automatic edge detection algorithm (RVG-auto) to define the left ventricular region of interest, increased from a resting value of 53.5% (+/- 4.9%) to 71.9% (+/- 6.8%) during isoproterenol infusion. Mean LVEF, determined with RVG by use of visual inspection (RVG-manual) to define the left ventricular region of interest increased from a resting value of 51.6% +/- 3.8% to 67.0% +/- 5.6% during isoproterenol infusion. Using 2-DE and the bullet formula to calculate left ventricular volume (LVV = 5/6 x cross-sectional area x length), mean LVEF increased from 52.3% (+/- 3.50) to 74.7% (+/- 5.0%). Using 2-DE area measurements and Teicholz formula, mean LVEF increased from 48.9% (+/- 5.1%) to 69.5% (+/- 6.0%). Using M-mode echocardiographic left ventricular diameter measurements and Teicholz formula, mean LVEF increased from 52.3 (+/- 9.0%) to 78.3% (+/- 8.1%). Before and during isoproterenol infusion, the mean LVEF values calculated by RVG agreed closely with mean LVEF values calculated from M-mode and 2-DE. Correlation coefficients determined from linear regression analysis of LVEF by echocardiography vs LVEF by radionuclide ventriculography ranged from 0.79 to 0.88. Correlation coefficients were higher and SEM were lower when LVEF was determined by RVG-manual, rather than by RVG-auto methods and when LVEF was calculated from 2-DE measurements, rather than from M-mode measurements.
Subject(s)
Dogs/physiology , Echocardiography/veterinary , Gated Blood-Pool Imaging/veterinary , Stroke Volume , Animals , Cardiac Output , Infusions, Intravenous , Isoproterenol/administration & dosage , Reference Values , Regression AnalysisABSTRACT
Balloon valvuloplasty was performed on two dogs with pulmonic valve stenosis. Immediately following balloon valvuloplasty, peak right ventricular systolic pressure declined from 92 to 44 mm Hg in the first dog and from 108 to 46 mm Hg in the second dog. The peak systolic pressure gradient across the pulmonic valve declined from 60 to 12 mm Hg in the first dog and from 84 to 22 mm Hg in the second dog. Hemodynamic improvement was sustained in both dogs at the time of recatheterization 3 months later. Both dogs tolerated the procedure well and there were no serious complications. It was concluded that balloon valvuloplasty offers an alternative to surgery for the treatment of valvular pulmonic stenosis in dogs. The exact indications for and limitations of balloon valvuloplasty must await the results of additional and more long-term studies.